サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655453

輸血診断学の世界市場

Blood Transfusion Diagnostics

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
輸血診断学の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

輸血診断学の世界市場は2030年までに55億米ドルに達する見込み

2024年に42億米ドルと推定される輸血診断学の世界市場は、分析期間2024-2030年にCAGR 4.7%で成長し、2030年には55億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである輸血診断機器は、CAGR 4.4%を記録し、分析期間終了までに17億米ドルに達すると予測されます。輸血診断キット＆試薬セグメントの成長率は、分析期間中CAGR 4.9％と推定されます。

米国市場は11億米ドル、中国はCAGR7.1％で成長予測

米国の輸血診断学市場は2024年に11億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4％と4.4％と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の輸血診断学市場- 主要動向と促進要因のまとめ

なぜ輸血診断学はヘルスケアで重要性を増しているのか？

輸血診断学は、年間数百万人の命を救う輸血の安全性と有効性を確保するために不可欠です。外傷、手術、慢性疾患の増加に伴い、輸血の需要は増加の一途をたどっており、輸血関連の合併症を予防するための信頼性の高い診断の必要性が高まっています。輸血診断学では、血液サンプルの適合性を確認し、HIV、肝炎、マラリアなどの感染症をスクリーニングするために、厳格な検査を実施しています。安全な輸血への需要が世界的に高まる中、特に外傷や手術の多い地域では、こうした診断技術は世界中の医療システムで不可欠なものとなっています。

技術革新はどのように輸血診断学の未来を形成しているのか？

技術革新は輸血診断学の進歩に重要な役割を果たしており、精度と効率の両方を向上させています。自動化された血液スクリーニング技術は、検査プロセスを合理化し、ヒューマンエラーを減らし、診断時間を短縮しています。核酸増幅検査（NAT）の使用は、感染症スクリーニングの感度を著しく向上させ、血液媒介病原体の早期発見を可能にしました。さらに、分子診断学と血清学における技術革新は、血液型検査と適合性検査の精度を高め、輸血に伴うリスクを最小限に抑えています。輸血診断におけるAIの統合も進んでおり、機械学習アルゴリズムが希少な血液型や抗体を特定するための予測能力を高めています。

輸血診断学市場が直面する課題とは？

進歩にもかかわらず、輸血診断学市場は、規制上のハードル、高コスト、高度なインフラの必要性など、いくつかの課題に直面しています。特に新興諸国では、診断検査の安全性や有効性を管理する規制が厳しく、新技術の承認や市場開拓を遅らせる可能性があります。さらに、先進的な血液スクリーニング技術を導入するためのコストは、特にリソースの少ない環境では、病院や診療所にとって法外なものとなる可能性があります。診断インフラへのアクセスが限られている地域では、自動化や熟練した専門家の不足が最新の輸血診断の採用を妨げる可能性があります。しかし、これらの地域ではヘルスケアシステムを強化し、診断サービスへのアクセスを拡大する取り組みが進められており、こうした障壁は徐々に緩和されつつあります。

輸血診断学市場の成長はいくつかの要因によってもたらされる

輸血診断学市場の成長は、安全な輸血に対するニーズの高まり、技術革新、新興市場における需要の高まりなど、いくつかの要因によって牽引されています。手術件数、外傷件数、がんや血液疾患などの治療件数の増加は、正確な血液検査に対する需要の高まりに寄与しています。自動化された検査プラットフォームや分子診断などの技術の進歩は、スクリーニング・プロセスをより迅速で信頼性の高いものにしており、市場の成長をさらに後押ししています。新興経済諸国ではヘルスケア支出やインフラ整備が増加しており、輸血診断学の拡大機会を生み出しています。さらに、安全な輸血の実践を促進する政府の取り組みや啓発キャンペーンも、市場の前進を後押ししています。

セグメント

用途（血液型分類、疾患スクリーニング）;最終用途（病院、血液銀行、診断研究所、血漿分画企業）;製品タイプ（機器、キット、試薬）

調査対象企業の例（注目の42社）

  • Abbott Laboratories
  • Bag Health Care GmbH
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Grifols International SA
  • Hologic, Inc.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • Quotient Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16226

Global Blood Transfusion Diagnostics Market to Reach US$5.5 Billion by 2030

The global market for Blood Transfusion Diagnostics estimated at US$4.2 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Blood Transfusion Diagnostic Kits & Reagents segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 7.1% CAGR

The Blood Transfusion Diagnostics market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Blood Transfusion Diagnostics Market - Key Trends & Drivers Summarized

Why Is Blood Transfusion Diagnostics Gaining Importance in Healthcare?

Blood transfusion diagnostics are critical to ensuring the safety and effectiveness of blood transfusions, a procedure that saves millions of lives annually. With rising incidences of trauma, surgeries, and chronic diseases, the demand for blood transfusions continues to grow, driving the need for reliable diagnostics to prevent transfusion-related complications. Blood transfusion diagnostics involve rigorous testing of blood samples to ensure compatibility and screen for infectious diseases like HIV, hepatitis, and malaria. As the demand for safe transfusions increases globally, particularly in regions with high rates of trauma and surgery, these diagnostic technologies are becoming essential in healthcare systems worldwide.

How Are Technological Innovations Shaping the Future of Blood Transfusion Diagnostics?

Technological innovations are playing a key role in advancing blood transfusion diagnostics, improving both accuracy and efficiency. Automated blood screening technologies have streamlined the testing process, reducing human error and speeding up diagnosis times. The use of nucleic acid amplification tests (NAT) has significantly improved the sensitivity of infectious disease screening, enabling earlier detection of blood-borne pathogens. Moreover, innovations in molecular diagnostics and serology have enhanced the precision of blood typing and compatibility testing, minimizing the risks associated with transfusions. The integration of AI in transfusion diagnostics is also emerging, with machine learning algorithms enhancing predictive capabilities for identifying rare blood types and antibodies.

What Challenges Does the Blood Transfusion Diagnostics Market Face?

Despite the advancements, the blood transfusion diagnostics market faces several challenges, including regulatory hurdles, high costs, and the need for advanced infrastructure. Strict regulations governing the safety and efficacy of diagnostic tests, particularly in developed countries, can delay the approval and market entry of new technologies. Additionally, the cost of implementing advanced blood screening technologies can be prohibitive for hospitals and clinics, particularly in low-resource settings. In regions with limited access to diagnostic infrastructure, the lack of automation and skilled professionals can hinder the adoption of modern transfusion diagnostics. However, initiatives to strengthen healthcare systems and expand access to diagnostic services in these regions are slowly mitigating these barriers.

The Growth in the Blood Transfusion Diagnostics Market Is Driven by Several Factors

The growth in the blood transfusion diagnostics market is driven by several factors, including the increasing need for safe blood transfusions, technological innovations, and rising demand in emerging markets. The growing number of surgeries, trauma cases, and treatments for conditions such as cancer and blood disorders contribute to the heightened demand for accurate blood testing. Technological advancements, such as automated testing platforms and molecular diagnostics, are making the screening process faster and more reliable, further boosting market growth. Emerging economies are witnessing an increase in healthcare spending and infrastructure development, creating opportunities for the expansion of blood transfusion diagnostics. Furthermore, government initiatives and awareness campaigns promoting safe transfusion practices are also helping to drive the market forward.

SCOPE OF STUDY:

The report analyzes the Blood Transfusion Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Blood Grouping, Disease Screening); End-Use (Hospitals, Blood Banks, Diagnostic Laboratories, Plasma Fractionation Companies); Product Type (Instruments, Kits & Reagents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Bag Health Care GmbH
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Grifols International SA
  • Hologic, Inc.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • Quotient Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Blood Transfusion Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Transfusion Safety and Screening Protocols
    • Increasing Prevalence of Chronic Diseases Requiring Blood Transfusions
    • Adoption of Advanced Blood Typing and Crossmatching Technologies
    • Growth in Blood Donation and Transfusion Rates Globally
    • Technological Innovations in Nucleic Acid Amplification Tests (NAT)
    • Expansion of Blood Screening for Infectious Diseases in Developing Regions
    • Rising Use of Automated Diagnostic Tools for Blood Testing
    • Growing Focus on Safe Transfusion Practices in Healthcare Facilities
    • Increasing Adoption of Molecular Diagnostics for Blood Screening
    • Advancements in Serological Testing for Better Blood Compatibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Transfusion Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Transfusion Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Grouping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Grouping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Blood Grouping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Disease Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Disease Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Disease Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Plasma Fractionation Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Plasma Fractionation Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Plasma Fractionation Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • CHINA
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Blood Transfusion Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • INDIA
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Blood Transfusion Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Blood Transfusion Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood Transfusion Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Blood Transfusion Diagnostics by Product Type - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Blood Transfusion Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Blood Transfusion Diagnostics by Application - Blood Grouping and Disease Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Blood Transfusion Diagnostics by Application - Percentage Breakdown of Value Sales for Blood Grouping and Disease Screening for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Blood Transfusion Diagnostics by End-Use - Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Blood Transfusion Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Diagnostic Laboratories and Plasma Fractionation Companies for the Years 2015, 2025 & 2030

IV. COMPETITION